Literature DB >> 14970733

Obesity and cancer risk among white and black United States veterans.

Claudine Samanic1, Gloria Gridley, Wong-Ho Chow, Jay Lubin, Robert N Hoover, Joseph F Fraumeni.   

Abstract

BACKGROUND: Obesity has been linked to excess risk for many cancers, but the evidence remains tenuous for some types. Although the prevalence of obesity varies by race, few studies of obesity-related cancer risk have included non-white subjects.
METHODS: In a large cohort of male US veterans (3,668,486 whites; 832,214 blacks) hospitalized with a diagnosis of obesity between 1969 and 1996, we examined risk for all major cancer sites and subsites. Person-years accrued from the date of first obesity diagnosis until the occurrence of a first cancer, death, or the end of the observation period (September 30, 1996). We calculated age- and calendar-year adjusted relative risks (RR) and 95% confidence intervals (CI) for cancer among white and black veterans, comparing obese men to men hospitalized for other reasons, with obesity status as time-dependent. For selected cancers, we performed additional analyses stratified by specific medical conditions related to both obesity and risk of those cancers. To determine whether obesity-related cancer risks differed significantly between white and black men, we evaluated heterogeneity of risk for each cancer site.
RESULTS: Among white veterans, risk was significantly elevated for several cancers, including cancers of the lower esophagus, gastric cardia, small intestine, colon, rectum, gallbladder and ampulla of vater, male breast, prostate, bladder, thyroid, and connective tissue, and for malignant melanoma, multiple myeloma, chronic lymphocytic leukemia (CLL), and acute myeloid leukemia (AML). Excess risks initially observed for cancers of the liver and pancreas persisted among men without a history of diabetes or alcoholism. Among black veterans, risks were significantly elevated for cancers of the colon, extrahepatic bile ducts, prostate, thyroid, and for malignant melanoma, multiple myeloma, CLL and AML.
CONCLUSIONS: Obese men are at increased risk for several major cancers as well as a number of uncommon malignancies, a pattern generally similar for white and black men. Due to the increasing prevalence of obesity and overweight worldwide, it is important to clarify the impact of excess body weight on cancer and to elucidate the mechanisms involved.

Entities:  

Mesh:

Year:  2004        PMID: 14970733     DOI: 10.1023/B:CACO.0000016573.79453.ba

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  89 in total

1.  Body mass, tobacco smoking, alcohol drinking and risk of cancer of the small intestine--a pooled analysis of over 500,000 subjects in the Asia Cohort Consortium.

Authors:  P Boffetta; W D Hazelton; Y Chen; R Sinha; M Inoue; Y T Gao; W P Koh; X O Shu; E J Grant; I Tsuji; Y Nishino; S L You; K Y Yoo; J M Yuan; J Kim; S Tsugane; G Yang; R Wang; Y B Xiang; K Ozasa; M Nagai; M Kakizaki; C J Chen; S K Park; A Shin; H Ahsan; C X Qu; J E Lee; M Thornquist; B Rolland; Z Feng; W Zheng; J D Potter
Journal:  Ann Oncol       Date:  2011-12-06       Impact factor: 32.976

2.  Body mass index, agricultural pesticide use, and cancer incidence in the Agricultural Health Study cohort.

Authors:  Gabriella Andreotti; Lifang Hou; Laura E Beane Freeman; Rajeev Mahajan; Stella Koutros; Joseph Coble; Jay Lubin; Aaron Blair; Jane A Hoppin; Michael Alavanja
Journal:  Cancer Causes Control       Date:  2010-08-22       Impact factor: 2.506

Review 3.  A review of African American-white differences in risk factors for cancer: prostate cancer.

Authors:  Irina Mordukhovich; Paul L Reiter; Danielle M Backes; Leila Family; Lauren E McCullough; Katie M O'Brien; Hilda Razzaghi; Andrew F Olshan
Journal:  Cancer Causes Control       Date:  2010-12-24       Impact factor: 2.506

4.  Alteration of strain background and a high omega-6 fat diet induces earlier onset of pancreatic neoplasia in EL-Kras transgenic mice.

Authors:  Eric C Cheon; Matthew J Strouch; Morgan R Barron; Yongzeng Ding; Laleh G Melstrom; Seth B Krantz; Bhargava Mullapudi; Kevin Adrian; Sambasiva Rao; Thomas E Adrian; David J Bentrem; Paul J Grippo
Journal:  Int J Cancer       Date:  2010-10-26       Impact factor: 7.396

5.  Potential role of leptin expression in hepatocellular carcinoma.

Authors:  S-N Wang; Y-T Yeh; S-F Yang; C-Y Chai; K-T Lee
Journal:  J Clin Pathol       Date:  2006-03-24       Impact factor: 3.411

6.  Obesity and the rising incidence of oesophageal and gastric adenocarcinoma: what is the link?

Authors:  Douglas A Corley
Journal:  Gut       Date:  2007-11       Impact factor: 23.059

7.  Voluntary exercise together with oral caffeine markedly stimulates UVB light-induced apoptosis and decreases tissue fat in SKH-1 mice.

Authors:  Yao-Ping Lu; Bonnie Nolan; You-Rong Lou; Qing-Yun Peng; George C Wagner; Allan H Conney
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-30       Impact factor: 11.205

8.  Obesity, weight gain, and risk of chronic myeloid leukemia.

Authors:  Sara S Strom; Yuko Yamamura; Hagop M Kantarijian; Jorge E Cortes-Franco
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-05       Impact factor: 4.254

9.  Nonradiation risk factors for thyroid cancer in the US Radiologic Technologists Study.

Authors:  Cari L Meinhold; Elaine Ron; Sara J Schonfeld; Bruce H Alexander; D Michal Freedman; Martha S Linet; Amy Berrington de González
Journal:  Am J Epidemiol       Date:  2009-11-30       Impact factor: 4.897

10.  Adipocyte-Derived Lipids Mediate Melanoma Progression via FATP Proteins.

Authors:  Maomao Zhang; Julie S Di Martino; Robert L Bowman; Nathaniel R Campbell; Sanjeethan C Baksh; Theresa Simon-Vermot; Isabella S Kim; Pearce Haldeman; Chandrani Mondal; Vladimir Yong-Gonzales; Mohsen Abu-Akeel; Taha Merghoub; Drew R Jones; Xiphias Ge Zhu; Arshi Arora; Charlotte E Ariyan; Kivanç Birsoy; Jedd D Wolchok; Katherine S Panageas; Travis Hollmann; Jose Javier Bravo-Cordero; Richard M White
Journal:  Cancer Discov       Date:  2018-06-14       Impact factor: 39.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.